Category: Include on Menu
-

Nvidia Surpasses Expectations with Strong Quarterly Results, Shares Surge After Hours
Nvidia (NASDAQ:NVDA) delivered impressive financial results for the quarter ending April 27, surpassing analysts’ projections. The American tech giant reported revenues of $44.1 billion, exceeding the consensus estimate of $43.31 billion. This represents a 12% increase over the previous quarter and a remarkable 69% growth compared to the same period last year. Earnings per share…
-

Dow Jones, S&P, Nasdaq: U.S. Stock Markets Dip as Earnings Reports Roll In.
U.S. stock markets saw declines on Wednesday, with the S&P 500, Dow Jones, and Nasdaq all posting losses. Companies like Macy’s and Abercrombie & Fitch reported mixed results, while Nvidia’s earnings were highly anticipated. The bond market reacted moderately as the Fed’s minutes revealed no changes in interest rates, amid ongoing inflation concerns. U.S. stock…
-

U.S. Stocks Close Lower Ahead Of Nvidia Earnings
After showing a lack of direction throughout much of the session, stocks moved to the downside in the latter part of the trading day on Wednesday. The major averages all moved lower late in the day partly offsetting the strong gains posted in the previous session. The Dow declined 244.95 points or 0.6 percent to…
-

Apple Could Benefit From Tariffs, Says Analyst
Amid ongoing concerns about tariffs, one Wall Street firm is presenting a surprising viewpoint: Apple (NASDAQ:AAPL) might actually gain from the current trade disruptions. In a fresh report, Loop Capital reaffirmed its Hold rating on Apple and kept its price target steady at $215. The firm suggested that shifts in production timing and pricing, driven…
-

iTeos Therapeutics Stock Jumps Following Operational Closure Announcement
Stock in iTeos Therapeutics Inc (NASDAQ:ITOS) climbed 21% following the company’s disclosure that its Board of Directors plans to discontinue business operations while concentrating on divesting company assets. The development-stage biotechnology enterprise, recognized for advancing cancer immunotherapy treatments, is currently evaluating the divestiture of critical properties including EOS-984, EOS-215, and an early-stage weight management program…
-

Telegram Announces AI Integration Deal with Elon Musk’s xAI Company
The messaging service Telegram has revealed a strategic alliance with Elon Musk’s artificial intelligence venture, xAI. This collaboration will introduce xAI’s Grok conversational AI system to Telegram’s extensive global user community. Pavel Durov, Telegram’s chief executive, disclosed this development through a post on the X social network. The incorporation of Grok AI capabilities into Telegram’s…
-

Bitdeer Shares Decline Following Critical Research Report
Shares of Bitdeer Technologies (NASDAQ:BTDR) dropped 4% following the publication of a critical analysis by Callisto Research, which has taken a bearish position on the bitcoin mining enterprise. The research organization issued an extensive examination challenging the company’s operational transparency, corporate oversight, and market pricing, resulting in downward pressure on the stock. The cryptocurrency mining…
-

Skechers Investment Rating Cut Following 3G Capital Acquisition
Investment firm TD Cowen has reduced its rating on Skechers (NYSE:SKX) from a positive recommendation to neutral positioning this Wednesday, citing the elimination of opportunities for alternative acquisition proposals after 3G Capital’s takeover announcement. “We are downgrading to Hold as the window for another bidder for Skechers to emerge has closed,” the analysts wrote. The…
-

OpenAI’s Restructuring May Lay Foundation For Future IPO
OpenAI’s ongoing corporate restructuring could lay the foundation for a potential initial public offering (IPO), though no firm plans have been made. CFO Sarah Friar noted at the Dublin Tech Summit that going public is a possibility, but emphasized that the company must be internally prepared and the broader market must be favorable before taking…
-

Goldman Sachs Recommend Gold And Oil In Long-run Portfolios
Goldman Sachs is urging long-term investors to reevaluate gold and oil’s roles in their portfolios. In a strategic note, the bank recommends a higher allocation to gold and a lower one to oil over the next five years, citing their historical effectiveness as hedges. “Positive long-run allocations to gold and enhanced oil futures are optimal…